RT Journal Article
SR Electronic
T1 A dataset of multi-contrast unbiased average MRI templates of a Parkinson’s disease population
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.06.22277331
DO 10.1101/2022.07.06.22277331
A1 Madge, Victoria
A1 Fonov, Vladimir S
A1 Xiao, Yiming
A1 Zou, Lucy
A1 Jackson, Courtney
A1 Postuma, Ronald B
A1 Dagher, Alain
A1 Fon, Edward A
A1 Collins, D Louis
YR 2022
UL http://medrxiv.org/content/early/2022/07/10/2022.07.06.22277331.abstract
AB Parkinson’s disease (PD) is a complex neurodegenerative disorder affecting regions such as the substantia nigra (SN), red nucleus (RN) and locus coeruleus (LC). Processing MRI data from patients with PD requires anatomical structural references for spatial normalization and structural segmentation. Extending our previous work [1][2], we present multi-contrast unbiased MRI templates using nine 3T MRI modalities: T1w, T2*w, T1-T2* fusion, R2*, T2w, PDw, fluid-attenuated inversion recovery (FLAIR), improved susceptibility-weighted imaging (CLEAR-SWI) [3], and neuromelanin-sensitive MRI (NM). Using our previous methods to build unbiased average templates [4], 1 mm isotropic voxel size templates were created, along with 0.5 mm isotropic whole brain templates and 0.3 mm isotropic templates of the midbrain. All templates were created from 126 PD patients (44 female; ages=40-87), and 17 healthy controls (13 female; ages=39-84), except the NM template, which was created from 85 PD patients and 13 controls, respectively. The dataset is available on the NIST MNI Repository via the following link: http://nist.mni.mcgill.ca/multi-contrast-pd126-and-ctrl17-templates/.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Weston Grant.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Research Ethics Board of the McGill University Health Center (MUHC) gave ethical approval for this work (C-BIG general protocol: 2017-330, 15-944-MUHC; C-BIG imaging protocol: 2019-4759; QPN protocol: 2015-143, MP-CUSM-NEU-14-053, MP-37-2015-143).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at: http://nist.mni.mcgill.ca/multi-contrast-pd126-and-ctrl17-templates/ http://nist.mni.mcgill.ca/multi-contrast-pd126-and-ctrl17-templates/